en

Trichloroethylene poses risks to workers and consumers, EPA says

Draft assessment confirms concerns about health effects of chlorinated solvent




en

Gilead buys immuno-oncology-focused Forty Seven

The $4.9 billion deal adds a mid-stage cancer drug to the big biotech's pipeline




en

ACS Strategic Plan highlights recent accomplishments




en

Julie Zimmerman named editor in chief of <i>Environmental Science and Technology</i>




en

Coronavirus cancels chemical events

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on




en

Gilead and Moderna lead on coronavirus treatments

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine




en

Biogen to develop zinc finger therapies with Sangamo




en

First in vivo CRISPR gene editing in humans




en

Genentech strikes cancer drug deal with Bicycle




en

BASF aims for 30% women in leadership




en

Genetic signature links bacterial toxin to colon cancer

Colibactin causes key cancer mutations




en

C16 raises funds for palm oil fermentation




en

Calysta and Adisseo plan fish feed venture in Asia




en

Orionis Biosciences launches with Novartis pact




en

South Korean joint venture to make hydrogen peroxide from steel byproduct




en

Scientists' favorite DIY lab equipment, and making lab trash live on




en

How to make aziridines from olefins without expensive metals

Double bonds form nitrogen-containing 3-membered rings thanks to a reactive yet fleeting oxaziridine intermediate




en

Jennifer Doudna's tips for new entrepreneurs

As the founder of multiple biotech firms, C&EN's guest editor has learned a thing or two about the challenges and triumphs of starting a company. We asked her to share her best advice for budding academic entrepreneurs




en

Cristina Sáenz de Pipaón wants to put CO<sub>2</sub> to good use

Her company, Orchestra Scientific, is developing membrane technology to separate carbon dioxide from other gases and use it as a product




en

Amy Ripka on being a CEO: ‘Nobody ever got anywhere by listening to no'

Lucy Therapeutics founder is taking an atypical approach to finding drugs for central nervous system diseases




en

Kiran Mazumdar-Shaw on her career: ‘I call myself an accidental entrepreneur'

Barred as a woman from becoming a brewer in India, Mazumdar-Shaw instead founded biotech firm Biocon and today focuses on affordable health care




en

Yamuna Krishnan's goal: Find drugs for neurodegenerative diseases

Her company, Esya Labs, is developing DNA nanodevices that track drug responses, screen for new therapies, and more




en

Paula Hammond on women in science: Life will always be busy; start a company anyway

The MIT chemical engineering head is charting a course into the start-up world with LayerBio




en

Naomi Halas on being a scientist: ‘We need to be attracted to the big, hard problems'

Nanotech pioneer aims to pursue grand challenges rather than just write about them




en

A day with Jennifer Doudna: Trying to keep up with one of the world's most sought-after scientists

The gene-editing tool CRISPR-Cas9 rerouted Doudna's career path. What hasn't changed for the renowned scientist and serial entrepreneur? Living and breathing the science




en

CRISPR technology: Where female entrepreneurs thrive

Dozens of women lead CRISPR-based projects worldwide. Here are a few who've built start-ups around the technology




en

C&EN's 2020 Trailblazers: Celebrating badass women entrepreneurs in chemistry

With guest editor Jennifer Doudna, CRISPR pioneer




en

Gilead y Moderna lideran los tratamientos contra el coronavirus

Gilead toma ventaja gracias a un antiviral, mientras que Moderna está buscando una nueva vacuna ARNm.




en

C&EN's Chemistry in Pictures goes meta

Our collection of chemistry photos will help train an algorithm to recognize lab materials, vessels, and processes




en

Coronavirus forces cancellations of scientific meetings

Spring lineup of conferences and events frequented by chemists is slashed




en

How international students can share their culture in the lab

Creating more opportunities for dialogue is just the first step




en

Firmenich to buy French pine chemical firm

DRT brings sustainable fragrance ingredients and industrial additives




en

Merck and Princeton scientists create method to map cell-surface microenvironments

The technique, called MicroMapping, identifies potential protein interactions on and between cells




en

Finding comets' hidden nitrogen

Ammonium salts may serve as nitrogen reservoirs on the icy bodies, suggesting a common origin for comets and the sun




en

India set to boost science budgets

Quantum technology, energy materials, and genomics are priorities




en

How COVID-19 is changing my graduate school experience




en

ACS launches graduate student organizations




en

Bryan Brooks named editor in chief of <i>Environmental Science and Technology Letters</i>




en

Genentech Foundation provides $3 million grant to ACS Bridge Project




en

Culture Biosciences raises $15 million for bioreactor service




en

Gates, Wellcome, and Mastercard give $125 million for coronavirus treatments




en

Syngenta backs sterile pollen start-up




en

Asahi Kasei to buy automotive upholstery fabric maker Adient




en

Neste invests in plastic recycling and hydrogen firms




en

Chemours opens research facility in Delaware




en

Dishing on dishwashing for a greener planet and playing games in a glove box




en

The end of enterprise resource planning

Chemical companies prepare as the monolithic information technology platform known as ERP undergoes radical transformation




en

Leaks of CFCs threaten ozone layer recovery and climate, researchers say

Aging equipment and plastic foam release chemicals




en

Air quality improvements boosted California's agriculture industry

Lower ozone levels led to higher grape and almond yields-and decarbonizing the state's economy could provide a further boost




en

Sanofi, Regeneron test arthritis drug against COVID-19

New study explores whether dampening IL-6 could address serious coronavirus infections